This course was last updated on
October 10, 2016
CME credit has expired.


Kim Margolin, MD, analyzes 4 key studies in metastatic melanoma, considering the clinical implications and application of several new classes of treatment.

Listen to expert commentary on recent studies.

Proceed at your own pace and in any order. Each commentary runs approximately 5 minutes.

Compare your knowledge against your peers.

Download summary slides to your library.

Content Areas

  • Treatment selection
  • OPTiM trial
  • KEYNOTE-001 trial
  • Combination treatment

This program was developed for oncologists, hematologist/oncologists, dermatologists, and other health care professionals who care for patients with metastatic melanoma.

This activity is supported by educational funding provided by Amgen and Prometheus Laboratories Inc.


Kim Margolin, MD

Kim Margolin, MD

Clinical Professor and Staff Physician Department of Medical Oncology
City of Hope National Medical Center
Duarte, California

Enter your information to begin.
CME Credit
Available Credit: 1.00 AMA PRA Category 1 Credit™.
Course Opens: October 10, 2016
Course Expires: October 09, 2017
Target Audience Oncologists
Other Health Care Providers